4//SEC Filing
Posner Christopher 4
Accession 0001209191-23-054332
CIK 0001346830other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:37 PM ET
Size
5.1 KB
Accession
0001209191-23-054332
Insider Transaction Report
Form 4
Posner Christopher
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2023-11-02$1.22/sh−3,796$4,631→ 164,411 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001748265
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:37 PM ET
- Size
- 5.1 KB